Abstract
Selective androgen receptor modulators (SARM) are a prominent group of compounds for being misused in sports owing to their advantageous anabolic properties and reduced side effects. To target the preventive doping control analysis in relevant compounds, the challenge is to predict the metabolic fate of a new compound. For aryl-propionamide-derived SARM, an in vitro assay employing microsomal and S9 human liver enzymes was developed to simulate phase-I and phase-II metabolic reactions. In vitro metabolic profiles and the structure-metabolic relationship were compared between four structurally modified substrates. Accurate mass measurements were used to characterize the synthesized metabolites, and also collision-induced dissociation was examined to suggest the methodological approach to monitor the prohibited use of aryl-propionamide-derived drug candidates. Subsequent phase-I and phase-II metabolic reactions were successfully combined in one in vitro assay. The main routes of phase-I modifications involved the hydrolysis of ether linkage, monohydroxylation, and hydrolytic cleavage of the amide bond. Nitro-reduction and deacetylation were reactions observed for substrates possessing the corresponding functionality. SARM metabolites were analyzed in negative ion electrospray ionization and detected as deprotonated species [M-H]-. The main metabolic modifications were observed to occur in the B-ring side, and collision-induced dissociation resulted in the product ions originating from the A-ring side of the compound. These structure-specific ions may be monitored as target ions in the routine doping control.
Footnotes
-
We thank the Manfred Donike Institute for Doping Analysis, Cologne, and the Federal Office of Sports, Switzerland, for supporting the presented work.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.107.017954.
-
ABBREVIATIONS: SARM, selective androgen receptor modulator(s); ACN, acetonitrile; AR, androgen receptor; CID, collision-induced dissociation; ESI, electrospray ionization; LC, liquid chromatography; MS, mass spectrometry; MS/MS, tandem mass spectrometry; PAPS, adenosine 3′-phosphate 5′-phosphosulphate; TFA, trifluoroacetic acid; UDPGA, uridine 5′-diphosphoglucuronic acid; amu, atomic mass unit(s).
- Received August 8, 2007.
- Accepted December 17, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|